Regulatory Action Ahead for Entod Pharma: CDSCO directs Gujarat FDCA to act on PresVu claims Farhat Nasim7 Oct 2024 4:55 PM ISTNew Delhi: Further challenges mount for Entod Pharmaceuticals as the Central Drugs Standard Control Organisation (CDSCO) has directed the Food and...
DCGI suspends permission to Entod Pharma to manufacture, market PresVu, What next for the Company? Ruchika Sharma12 Sept 2024 3:06 PM ISTNew Delhi: In response to the various alleged misleading claims made by Entod Pharma in respect to its Opthalmologic product, Drugs Controller General...
Entod Pharma wins DCGI nod for PresVu eye drops to treat Presbyopia Ruchika Sharma4 Sept 2024 4:07 PM ISTNew Delhi: ENTOD Pharmaceuticals has received final approval from the Drug Controller General of India (DCGI) for its PresVu eye drops.. This...
Aceclidine-based Eye Drops Effective in Treating Presbyopia, reveals phase 3 trial Jacinthlyn Sylvia7 April 2024 7:15 PM ISTThe recent press release from a prominent biopharmaceutical company, LENZ Therapeutics, Inc. unveiled promising findings from its Phase 3 CLARITY...
FDA approves pilocarpine hydrochloride eye drops for presbyopia Dr. Kamal Kant Kohli20 Oct 2023 10:30 AM ISTThe US Food and Drug Administration (FDA) has approved pilocarpine hydrochloride ophthalmic solution (Qlosi) for adults with presbyopia.The approval...
Entod Pharmaceuticals Gets CDSCO Panel Nod To study Pilocarpine Hydrochloride for Treatment of Presbyopia Dr. Divya Colin21 July 2023 3:38 PM ISTNew Delhi: Entod Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Twice-daily Pilocarpine hydrochloride ok for improving near-visual acuity in presbyopia: Study Medha Baranwal26 May 2023 9:30 AM ISTUSA: Pilocarpine hydrochloride 1.25% administered twice daily in people with presbyopia led to more significant improvements in near-visual acuity at...
Viatris acquires Famy Life Sciences ophthalmology business for Rs 2,500 crore Ruchika Sharma8 Nov 2022 1:30 PM ISTViatris is taking over a business consisting of a strong ophthalmic portfolio of phase 3 clinical assets in diseases such as dry eye, presbyopia, and...
Twice daily pilocarpine HCI eye drops improve age related presbyopia: Phase 3 VIRGO trial Dr. Kamal Kant Kohli7 April 2022 10:30 PM ISTNORTH CHICAGO: New Phase 3 VIRGO trial data evaluating the safety and efficacy of pilocarpine HCI ophthalmic solution 1.25% (VUITY) in adults with...
1.25 % pilocarpine hydrochloride safe and effective against presbyopia, finds JAMA study Medical Dialogues Editorial Team16 March 2022 9:00 AM ISTUSA: AGN-190584 (Allergan, an AbbVie business) is an improved topical formulation of 1.25 percent pilocarpine hydrochloride intended for the treatment...
Topical lipoic acid choline ester eye drops improve near visual acuity; study finds Medical Dialogues Editorial Team22 Jan 2022 9:00 AM ISTPresbyopia is caused by a combination of ciliary body, vitreous body, and crystalline lens degeneration. The degenerative changes in the crystalline...
FDA approves first ever Once-daily eye drops for presbyopia Dr. Kamal Kant Kohli1 Nov 2021 9:00 AM ISTNORTH CHICAGO: The US Food and Drug Administration has approved once-daily eye drops, Vuity (pilocarpine HCl ophthalmic solution) 1.25% for the...
